Vepsitamab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Vepsitamab Usage And Synthesis

Uses

Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that binds to CD3 on T cells and MUC17 expressed on tumor cells, mediates redirected tumor cell lysis, and induces T cell activation and proliferation[1].

References

[1] Joseph Chao, et al. Trial in progress: A phase I study of AMG 199, a half-life extended bispecific T-cell engager (HLE BiTE) immune therapy, targeting MUC17 in patients with gastric and gastroesophageal junction (G/GEJ) cancer. 2020 ASCO Annual Meeting I.

Vepsitamab(2413453-53-7)Related Product Information

• Talquetamab
• Sulesomab
• Atidortoxumab
• Atinumab
• Morolimumab
• Research Grade Acazicolcept (DHC83404)
• Gedivumab
• Samrotamab
• Acapatamab
• Cabiralizumab